Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

BACKGROUND: BNT162b2 is a lipid nanoparticle–formulated, nucleoside-modified RNA vaccine encoding a prefusion-stabilized, membrane-anchored severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) full-length spike protein. BNT162b2 is highly efficacious against coronavirus disease 2019 (Covid-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Stephen J., Moreira, Edson D., Kitchin, Nicholas, Absalon, Judith, Gurtman, Alejandra, Lockhart, Stephen, Perez, John L., Pérez Marc, Gonzalo, Polack, Fernando P., Zerbini, Cristiano, Bailey, Ruth, Swanson, Kena A., Xu, Xia, Roychoudhury, Satrajit, Koury, Kenneth, Bouguermouh, Salim, Kalina, Warren V., Cooper, David, Frenck, Robert W., Hammitt, Laura L., Türeci, Özlem, Nell, Haylene, Schaefer, Axel, Ünal, Serhat, Yang, Qi, Liberator, Paul, Tresnan, Dina B., Mather, Susan, Dormitzer, Philip R., Şahin, Uğur, Gruber, William C., Jansen, Kathrin U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461570/
https://www.ncbi.nlm.nih.gov/pubmed/34525277
http://dx.doi.org/10.1056/NEJMoa2110345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461570/
https://www.ncbi.nlm.nih.gov/pubmed/34525277
http://dx.doi.org/10.1056/NEJMoa2110345

Ejemplares similares